Puramino is the newest of the three amino-acid-based infant formulas available in the US. Launched in 2014 by Mead Johnson Nutrition (acquired by Reckitt Benckiser in 2017), Puramino joined an AAF category where Neocate (Nutricia, 1984) and EleCare (Abbott, 2003) had been sole competitors for over a decade. Puramino's commercial positioning leveraged Mead Johnson's existing Nutramigen CMPA relationships, when an infant's diagnosed cow milk protein allergy failed to respond to Nutramigen (the company's eHF product), Puramino offered a same-parent-company step-up to AAF without requiring the family to switch to a competitor brand.
Puramino is Reckitt / Mead Johnson's amino-acid-based infant formula, launched 2014 as the third US AAF entrant after Neocate and EleCare. It contains prebiotic blend (PDX and GOS) but no probiotic. Indicated for severe CMPA, multiple food allergies, and eosinophilic esophagitis. FDA-registered under 21 CFR 107 with full Hypoallergenic classification. Typical insurance coverage with medical necessity documentation. Same parent company as Nutramigen (eHF), simplifying clinical step-up paths. Not sold via Organic's Best Shop, this hub completes the US amino-acid tier coverage for Atlas reference.
Company snapshot
| Attribute | Value |
|---|---|
| Parent company | Reckitt Benckiser (acquired Mead Johnson 2017) |
| Brand operator | Mead Johnson Nutrition |
| Founded | 2014 (Puramino launch under Mead Johnson) |
| Corporate HQ | Slough, UK (Reckitt); Glenview, IL (US Mead Johnson) |
| Manufacturing | US, Netherlands |
| Product category | Amino-acid-based infant formula (AAF) |
| FDA registered as infant formula | Yes (21 CFR 107) |
| Sold by Organic's Best Shop | No |
| Insurance coverage | Typically yes with medical necessity docs |
| Cost without insurance | Very high, similar to Neocate/EleCare |
Where Puramino fits
The US amino-acid category has three products. Each fills a slightly different niche in terms of formulation and clinical preference:
| Feature | Neocate Syneo | EleCare | Puramino |
|---|---|---|---|
| Parent company | Nutricia/Danone | Abbott | Reckitt/Mead Johnson |
| Launch year | 1984 (Syneo mid-2010s) | 2003 | 2014 |
| Prebiotic system | scGOS/lcFOS | None | PDX and GOS |
| Probiotic | B. breve M-16V | None | None |
| Key distinction | Oldest clinical track record; synbiotic | Simplest ingredient list; FDA history | Same parent company as Nutramigen eHF |
| Manufacturing concentration risk | Nutricia facilities (multiple) | Sturgis, MI (single facility) | Reckitt facilities (multiple) |
For the full AAF tier context, see:
What Puramino adds to the AAF category
1. Same-parent-company step-up from Nutramigen
The CMPA clinical pathway progresses:
- Partially hydrolyzed, not indicated for diagnosed CMPA
- Extensively hydrolyzed (eHF), first-line for CMPA (Nutramigen, Alimentum, Gerber Extensive HA)
- Amino-acid-based (AAF), second-line when eHF fails
If a pediatric GI or allergist starts with Nutramigen (Reckitt's eHF) and the infant fails to respond, Puramino offers:
- Same manufacturer continuity (supplier relationships, insurance formularies, parent familiarity)
- Similar preparation and packaging conventions
- Coordinated clinical messaging from Mead Johnson's medical affairs
This matters practically, insurance often requires documented eHF failure before approving AAF, and staying within the same parent company's product family can streamline that process.
See the Nutramigen brand hub for the sibling eHF profile.
2. PDX and GOS prebiotic blend
Puramino includes a prebiotic combination of polydextrose (PDX) and galactooligosaccharides (GOS), different from Neocate Syneo's scGOS/lcFOS approach. Both are intended to support gut microbiota diversity in AAF-fed infants who would otherwise lack milk-derived prebiotic substrates. No probiotic is included.
The clinical significance of prebiotic choice in AAF is not definitively established, both Puramino's PDX, GOS, and Neocate's scGOS/lcFOS have supporting literature; comparative head-to-head efficacy data is limited.
For the underlying prebiotic explainers:
3. Distribution via mainstream retail and specialty
Puramino is sold through:
- Reckitt/Mead Johnson specialty distribution networks
- Major retail pharmacies (CVS, Walgreens, Rite Aid)
- Amazon
- Specialty pediatric pharmacies
This distribution footprint is slightly broader than Neocate's traditional specialty-pharmacy-heavy model, though all three AAFs are effectively insurance-pharmacy products for most families.
The CMPA hierarchy: reminder
For the full clinical framework, see our cow milk protein allergy explained pillar. Briefly, Puramino is appropriate when:
- Extensively hydrolyzed formula (eHF) trial failed to resolve CMPA symptoms (approximately 10% of CMPA cases)
- Multiple food protein allergies are documented
- Eosinophilic esophagitis is histologically confirmed
- Severe anaphylactic risk requires zero peptide exposure
- Short gut syndrome or severe malabsorption
Puramino is not appropriate for:
- Uncomplicated fussiness, gas, or colic without diagnosed CMPA
- Reflux (even if GERD) without underlying protein allergy, see reflux and GERD in formula-fed babies
- Colic without documented protein allergy, see colic and formula choice
Product line
Puramino Infant (flagship)
Amino-acid-based infant formula for 0-12 months, FDA-registered under 21 CFR 107, with PDX and GOS prebiotic blend.
See the SKU record: Puramino Infant.
Puramino Junior (12+ months)
Amino-acid formula for toddlers with continued CMPA or related indications. Not regulated under 21 CFR 107 (toddler age range).
Regulatory and insurance context
FDA 21 CFR 107 status
Puramino Infant is FDA-registered as infant formula with the FDA's recognized "Hypoallergenic" classification, the same regulatory tier as Neocate and EleCare.
Insurance coverage
Typical US coverage pathway:
- Pediatric GI or allergist diagnosis of qualifying condition
- Documented eHF trial failure (2-4 weeks minimum) for standard CMPA
- Letter of medical necessity submitted to insurer
- Coverage under pharmacy benefit or DME depending on insurer
- Medicaid/CHIP typically covers with prescription
- WIC varies by state and typically requires medical authorization
Out-of-pocket cost
Similar to Neocate and EleCare, $65-95 per can, with typical young infant consumption producing $7,000-13,000+ annual out-of-pocket cost if uninsured. Access to appropriate AAF coverage remains a significant equity issue in US pediatric allergy care.
Practical notes for parents
Same-company advantage (if Nutramigen was the eHF trial)
If your pediatrician prescribed Nutramigen as the eHF attempt and it failed:
- Insurance step-up to Puramino is often streamlined
- Preparation methods are similar
- Reckitt/Mead Johnson's patient support programs cover both products
- Some pharmacies stock both and can facilitate transition
Introducing Puramino
- Taste adaptation: free amino acids are bitter; most infants resist initial feeds. 3-7 days of persistence typically produces acceptance.
- Preparation: standard Cronobacter prevention (70°C water per WHO/CDC/FDA guidance). See how to prepare baby formula safely.
- Stool monitoring: AAF-fed infant stools may differ from eHF stools (slightly different color and consistency is normal).
- Growth: pediatric follow-up every 2-4 weeks initially.
Duration of use
Like all AAFs:
- Most CMPA resolves by age 3-5
- Pediatric allergist-supervised milk challenges determine stepdown timing
- Transition to eHF, then to standard formula, then to cow milk is the typical sequence
Editorial notes from María
Puramino completes the US amino-acid-based infant formula tier. With Neocate, EleCare, and Puramino documented, the Atlas now covers the full CMPA clinical hierarchy from partially hydrolyzed (HiPP HA, Gerber GentlePro, Enfamil Gentlease, NAN HA) through extensively hydrolyzed (Nutramigen, Alimentum, Gerber Extensive HA) to amino-acid-based (Neocate, EleCare, Puramino).
For parents navigating CMPA diagnosis, Puramino is worth knowing about primarily because of the Nutramigen parent-company connection. If your pediatrician prescribes Nutramigen as first-line and the trial fails, understanding that Puramino exists as an in-network step-up option can smooth what is often a difficult clinical transition.
The three US AAFs are clinically similar enough that the choice among them typically comes down to insurance formulary, clinician familiarity, and specific infant tolerability, not clear evidence-based superiority of any one product.
Puramino is not sold by Organic's Best Shop. This hub exists to complete the Atlas's amino-acid tier coverage for the families who need this information.
For related profiles:
- Neocate: Nutricia AAF peer (oldest, synbiotic)
- EleCare: Abbott AAF peer (simplest, Sturgis-only)
- Nutramigen: Reckitt's eHF sibling (first-line CMPA)
- Alimentum: Abbott eHF peer
Frequently asked questions
The questions below come up most often when families navigate PurAmino after a CMPA, FPIES, or EoE diagnosis where pediatric specialists recommend an amino-acid formula. Answers reference the FDA 21 CFR 107.30 framework and AAP/NASPGHAN clinical guidance on AAF.
What's the difference between PurAmino and Nutramigen?
Is PurAmino available without a prescription?
How does PurAmino compare to Neocate and EleCare?
How long does PurAmino take to work for severe CMPA or FPIES?
Does PurAmino taste different from regular formula?
Can I switch between PurAmino, Neocate, and EleCare?
Is PurAmino safe for premature or low-birth-weight infants?
Primary sources
- Puramino / Mead Johnson Nutrition: Product information and clinical use guidance. puraminoinfant.com
- FDA: Infant Formula Guidance and 21 CFR 107 regulation. fda.gov
- NASPGHAN: Clinical guidelines on CMPA management. naspghan.org
- AAP: Clinical Report on food allergy prevention and management. aap.org
- EAACI: European Academy of Allergy and Clinical Immunology guidelines. eaaci.org
Related reading
This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.
- Neocate Syneo vs Puramino - Two Bioactive Amino Acid Formulas Head-to-Head (Nutricia Synbiotic vs Reckitt Prebiotic)
- Similac Alimentum vs Puramino - Cross-Manufacturer eHF to AAF Step-Up (Abbott eHF vs Reckitt AAF)
- Eosinophilic Esophagitis (EoE) in Infants — Introduction and Formula Implications
- FPIES — Food Protein-Induced Enterocolitis Syndrome in Infants
